816 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
BMY Bristol-Myers Squibb Company $61.3 $100.03B N/A
Article Searches
Novartis Reports Data on Cosentyx for Psoriatic Arthritis http://www.zacks.com/stock/news/428752/novartis-reports-data-on-cosentyx-for-psoriatic-arthritis?cid=CS-ZC-FT-428752 Jun 12, 2019 - Novartis (NVS) announces new data on psoriatic arthritis drug, Cosentyx.
Boost Your Portfolio's Health With These 3 Big Drug Stocks http://www.zacks.com/stock/news/428332/boost-your-portfolios-health-with-these-3-big-drug-stocks?cid=CS-ZC-FT-428332 Jun 12, 2019 - The large-cap pharma industry is doing well in 2019. Here are three stocks from the space that investors may consider betting on.
Insys Down on Bankruptcy News Amid Increasing Legal Expenses http://www.zacks.com/stock/news/428129/insys-down-on-bankruptcy-news-amid-increasing-legal-expenses?cid=CS-ZC-FT-428129 Jun 11, 2019 - Insys (INSY) crashes as it files for bankruptcy protection amid rising legal settlement dues.
Merck (MRK) to Buy Private Biotech Tilos for Up to $773M http://www.zacks.com/stock/news/427724/merck-mrk-to-buy-private-biotech-tilos-for-up-to-%24773m?cid=CS-ZC-FT-427724 Jun 11, 2019 - Merck (MRK) set to buy private preclinical biotech Tilos Therapeutics in a deal that could be worth up to $773 million
Sanofi (SNY) in Focus: Stock Moves 5.5% Higher http://www.zacks.com/stock/news/427295/sanofi-sny-in-focus-stock-moves-55-higher?cid=CS-ZC-FT-427295 Jun 10, 2019 - Sanofi (SNY) shares rose nearly 6% in the last trading session, amid huge volumes.
Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache http://www.zacks.com/stock/news/426292/pharma-stock-roundup-asco-update-fda-nod-for-llys-emgality-for-cluster-headache?cid=CS-ZC-FT-426292 Jun 07, 2019 - Pharma bigwigs present data from cancer studies at ASCO. Lilly's (LLY) CGRP Emgality gets FDA approval for episodic cluster headache in adults.
Novartis Appoints New Pharma Unit Head, Gives Other Updates http://www.zacks.com/stock/news/426279/novartis-appoints-new-pharma-unit-head-gives-other-updates?cid=CS-ZC-FT-426279 Jun 07, 2019 - Novartis (NVS) appoints Marie-France Tschudin as head of the pharma unit. The company also provides a few pipeline updates.
Celgene & Acceleron's BLA for Luspatercept Accepted by FDA http://www.zacks.com/stock/news/425862/celgene-accelerons-bla-for-luspatercept-accepted-by-fda?cid=CS-ZC-FT-425862 Jun 06, 2019 - Celgene (CELG) along with partner Acceleron submits application for luspatercept to the FDA.
Mallinckrodt Down After Agreement with DOJ for Litigation http://www.zacks.com/stock/news/425859/mallinckrodt-down-after-agreement-with-doj-for-litigation?cid=CS-ZC-FT-425859 Jun 06, 2019 - Mallinckrodt (MNK) expects to pay $15.4 million to DOJ in relation with the Questcor litigation.
Was ASCO Quieter for Big Drug/Biotech Stocks This Year? http://www.zacks.com/stock/news/425444/was-asco-quieter-for-big-drug-biotech-stocks-this-year?cid=CS-ZC-FT-425444 Jun 06, 2019 - The annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago sees cancer data presentations from several drug/biotech companies about the latest developments in treating cancer.

Pages: 1234567...82

<Page 2>